Immunisation following a two-dose regimen stimulated both systemic IgG to MOMP and antigen-specific cellular responses dominated by IFN-γ and IL-17A production, immune response signatures shown previously to be protective against chlamydial disease in representative vaccine-challenge models. The gene discussed is IL17A; the disease is chlamydia trachomatis infectious disease.